We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Maelor | LSE:MLR | London | Ordinary Share | GB00B2QBY649 | ORD 70P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 100.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:7668S
Maelor PLC
21 April 2008
21 April 2008
Maelor plc ('Maelor' or the 'Company')
Result of General Meeting
The Board of Maelor plc (AIM:MLR), the specialist hospital medicines group, is
pleased to announce that the ordinary resolutions and special resolutions
considered at the General Meeting, convened by the circular sent to shareholders
on 28 March 2008 and held today, were duly passed.
Following the passing of resolution 1, the 1 for 7 share consolidation of the
Company's existing ordinary shares will take place at the close of business
today, 21 April 2008 ('Share Consolidation'). Application has been made for the
admission of the consolidated ordinary shares to trading on AIM. It is expected
that admission will become effective on 22 April 2008, whereupon the Share
Consolidation will be effective and the issued share capital of the Company will
be 17,754,404 ordinary shares of 70 pence each. Apart from the change in
nominal value, the consolidated ordinary shares arising on implementation of the
Share Consolidation will have the same rights as the existing ordinary shares
including voting, dividend and other rights. The ISIN of the consolidated
ordinary shares is GB00B2QBY649.
Following the passing of resolution 6, the Company's name has been changed to IS
Pharma plc. Dealings in the Company's shares under the new name are expected to
commence on 28 April 2008. The ticker is ISPH.
The Board anticipates notifying the market of the completion of the acquisition
of Speciality European Pharma International AG on 28 April 2008.
- ENDS -
Enquiries:
Maelor plc Tel: +44(0) 1244 625150
Tim Wright - CEO
www.maelor.plc.uk
Financial Dynamics Limited Tel: +44(0) 20 7831 3113
Billy Clegg / Edward Westropp
Noble & Company Limited Tel: +44(0) 20 7763 2200
Matthew Hall / Sam Reynolds
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLFLFLVZBXBBX
1 Year Maelor Chart |
1 Month Maelor Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
